Werewolf Therapeutics, Inc. (HOWL)
0.9796
+0.07
(+7.65%)
USD |
NASDAQ |
Oct 09, 16:00
0.9792
0.00 (0.00%)
Pre-Market: 20:00
Werewolf Therapeutics EPS Diluted (Quarterly) : 0.0755 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0755 |
| March 31, 2026 | -0.2836 |
| December 31, 2025 | -0.1731 |
| September 30, 2025 | -0.3574 |
| June 30, 2025 | -0.3998 |
| March 31, 2025 | -0.4035 |
| December 31, 2024 | -0.4586 |
| September 30, 2024 | -0.3815 |
| June 30, 2024 | -0.3963 |
| March 31, 2024 | -0.3892 |
| December 31, 2023 | -0.3282 |
| September 30, 2023 | -0.2324 |
| Date | Value |
|---|---|
| June 30, 2023 | -0.1434 |
| March 31, 2023 | -0.3445 |
| December 31, 2022 | -0.3882 |
| September 30, 2022 | -0.4013 |
| June 30, 2022 | -0.5304 |
| March 31, 2022 | -0.5601 |
| December 31, 2021 | -0.6542 |
| September 30, 2021 | -0.5055 |
| June 30, 2021 | -2.500 |
| March 31, 2021 | -83.36 |
| December 31, 2020 | -0.7168 |
| September 30, 2020 | -0.2117 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.67M |
| Revenue (Quarterly) | 21.00M |
| Total Expenses (Quarterly) | 17.33M |
| Enterprise Value | 25.62M |
| Gross Profit Margin (Quarterly) | 88.32% |
| Profit Margin (Quarterly) | 17.48% |
| Earnings Yield | -75.40% |
| Normalized Earnings Yield | -66.01 |